Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms.
Saved in:
| Title: | Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms. |
|---|---|
| Authors: | Mosalem O; Division of Hematology and Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA. Electronic address: mosalem.osama@mayo.edu., Sonbol MB; Division of Hematology and Oncology-Mayo Clinic Cancer Center, Phoenix, AZ, USA. Electronic address: sonbol.mohamad@mayo.edu., Halfdanarson TR; Division of Medical Oncology, Professor of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: halfdanarson.thorvardur@mayo.edu., Starr JS; Division of Hematology and Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA. Electronic address: Starr.Jason@mayo.edu. |
| Source: | Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2023 Sep; Vol. 37 (5), pp. 101796. Date of Electronic Publication: 2023 Jun 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120682 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1594 (Electronic) Linking ISSN: 1521690X NLM ISO Abbreviation: Best Pract Res Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-1594 |
|---|---|
| DOI: | 10.1016/j.beem.2023.101796 |
